Indication
Squamous Cell Carcinoma Skin
2 clinical trials
3 products
Product
JK08Clinical trial
A Phase 1/2, Multicenter, Open Label, Dose Escalation & Dose Expansion Study of JK08, an IL-15 Antibody Fusion Protein Targeting CTLA-4, Monotherapy or in Combination in Patients With Unresectable Locally Advanced or Metastatic CancerStatus: Recruiting, Estimated PCD: 2025-10-17
Product
PembrolizumabClinical trial
Skin Cancer and Hyperthermia and Radiotherapy - SAHARA a Two-arm, Open-label, Randomized Controlled Phase II TrialStatus: Not yet recruiting, Estimated PCD: 2026-07-01